Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.Financial_Report.xls
10-Q - QUARTERLY REPORT - ASSEMBLY BIOSCIENCES, INC.v326006_10q.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R6.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R18.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R17.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R22.htm
EX-31.1 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex31-1.htm
EX-32.1 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex32-1.htm
EX-31.2 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex31-2.htm
EX-32.2 - CERTIFICATION - ASSEMBLY BIOSCIENCES, INC.v326006_ex32-2.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R5.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R19.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R11.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R15.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R14.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R12.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R20.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R23.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R16.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R21.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R3.htm
XML - IDEA: XBRL DOCUMENT - ASSEMBLY BIOSCIENCES, INC.R10.htm
v2.4.0.6
CONDENSED BALANCE SHEETS (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 23,560,079 $ 36,975,434
Other current assets 111,184 62,129
Total current assets 23,671,263 37,037,563
Computer equipment, net 8,107 8,218
Total assets 23,679,370 37,045,781
Current liabilities:    
Accounts payable 1,843,095 2,342,074
Accrued expenses 838,101 171,000
Total current liabilities 2,681,196 2,513,074
Commitments      
Stockholders' equity:    
Preferred stock, $.001 par value; 5,000,000 shares authorized, none issued 0 0
Common stock, $.001 par value; 50,000,000 shares authorized; 12,934,350 and 12,406,406 issued and outstanding at September 30, 2012 and December 31, 2011, respectively 12,934 12,406
Additional paid-in capital 109,513,645 102,049,385
Deficit accumulated during the development stage (88,528,405) (67,529,084)
Total stockholders' equity 20,998,174 34,532,707
Total liabilities and stockholders' equity $ 23,679,370 $ 37,045,781